Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.33B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$985M |
| 3 |
Eli Lilly
LLY
|
+$901M |
| 4 |
Toronto Dominion Bank
TD
|
+$796M |
| 5 |
Blackrock
BLK
|
+$544M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$857M |
| 2 |
NVIDIA
NVDA
|
+$803M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$676M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$671M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.21% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.12% |
| 4 | Healthcare | 6.97% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
iShares ESG Advanced MSCI EAFE ETF
DMXF
$972M
| $3M | ﹤0.01% |
44,487
-8,049
| -15% | -$546K |
|
|
CET
2602
Central Securities Corp
CET
$1.63B
| $2.99M | ﹤0.01% |
66,549
+2,521
| +4% | +$117K |
|
2603
Mercantile Bank Corp
MBWM
$1.06B
| $2.99M | ﹤0.01% |
68,824
+3,621
| +6% | +$168K |
|
2604
TG Therapeutics
TGTX
$7.46B
| $2.98M | ﹤0.01% |
75,692
+10,660
| +16% | +$359K |
|
2605
Phillips Edison & Co
PECO
$5.21B
| $2.98M | ﹤0.01% |
81,726
+9,250
| +13% | +$334K |
|
2606
NEOS S&P 500 High Income ETF
SPYI
$11.4B
| $2.98M | ﹤0.01% |
62,184
+9,262
| +18% | +$468K |
|
2607
Allegro MicroSystems
ALGM
$8.27B
| $2.96M | ﹤0.01% |
117,923
+48,554
| +70% | +$1.21M |
|
2608
IonQ
IONQ
$18.7B
| $2.96M | ﹤0.01% |
134,176
+14,898
| +12% | +$483K |
|
2609
Aurinia Pharmaceuticals
AUPH
$2.06B
| $2.96M | ﹤0.01% |
367,661
+145,179
| +65% | +$1.18M |
|
2610
Carpenter Technology
CRS
$27B
| $2.95M | ﹤0.01% |
16,303
-2,120
| -12% | -$409K |
|
2611
State Street SPDR S&P 1500 Value Tilt ETF
VLU
$784M
| $2.94M | ﹤0.01% |
15,994
+3,964
| +33% | +$746K |
|
2612
First Trust Multi Cap Value AlphaDEX Fund
FAB
$178M
| $2.94M | ﹤0.01% |
36,957
-640
| -2% | -$52.6K |
|
2613
First Commonwealth Financial
FCF
$2.18B
| $2.94M | ﹤0.01% |
188,826
+21,108
| +13% | +$343K |
|
2614
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$161M
| $2.94M | ﹤0.01% |
31,286
+3,147
| +11% | +$302K |
|
2615
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.54B
| $2.93M | ﹤0.01% |
186,019
-735,712
| -80% | -$12.2M |
|
2616
PUT
AbbVie
ABBV
$441B
| $2.93M | ﹤0.01% |
14,000
-6,000
| -30% | -$1.17M |
|
2617
CALL
Lam Research
LRCX
$416B
| $2.93M | ﹤0.01% |
40,300
-259,700
| -87% | -$20.5M |
|
2618
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.21B
| $2.93M | ﹤0.01% |
268,259
+25,765
| +11% | +$286K |
|
2619
Madrigal Pharmaceuticals
MDGL
$11.7B
| $2.92M | ﹤0.01% |
8,819
-2,571
| -23% | -$845K |
|
2620
Element Solutions
ESI
$9.46B
| $2.92M | ﹤0.01% |
129,101
-46,958
| -27% | -$1.2M |
|
2621
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.92B
| $2.92M | ﹤0.01% |
34,750
-4,128
| -11% | -$374K |
|
2622
Vanguard California Tax-Exempt Bond ETF
VTEC
$3.1B
| $2.91M | ﹤0.01% |
29,596
+24,096
| +438% | +$2.39M |
|
2623
Invesco Ultra Short Duration ETF
GSY
$3.88B
| $2.9M | ﹤0.01% |
57,917
+12,962
| +29% | +$650K |
|
|
GTM
2624
ZoomInfo Technologies
GTM
$1.18B
| $2.9M | ﹤0.01% |
290,131
+282,762
| +3,837% | +$2.96M |
|
2625
iShares Bitcoin Trust
IBIT
$46.8B
| $2.9M | ﹤0.01% |
61,926
+2,148
| +4% | +$114K |
|
Similar funds
Royal Bank of Canada's Q1 2025 Portfolio in Review
As of Q1 2025, Royal Bank of Canada held 7,428 positions worth $479B, down 4.4% from $501B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q1 2025 filing shows 373 new, 3,020 increased, 3,038 reduced and 434 closed positions. Its largest new stake was Sandisk: 233,868 shares worth $11.1M. The largest sale was HCA Healthcare, an estimated $857M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q1 2025 buy was Sandisk: 233,868 shares worth $11.1M.
- Royal Bank of Canada added most to Canadian Natural Resources in Q1 2025, an estimated $1.33B increase.
- Royal Bank of Canada's biggest Q1 2025 reduction was HCA Healthcare, cutting an estimated $857M.
- Royal Bank of Canada fully exited Aspen Technology Inc in Q1 2025, selling an estimated $42.5M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $479B portfolio in Q1 2025.
- Royal Bank of Canada opened 373 new positions and closed 434 in Q1 2025.
- Royal Bank of Canada's portfolio value fell 4.4% quarter-over-quarter to $479B.
Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.